CELL-MEDIATED IMMUNITY IN RENAL CELL CARCINOMA. PRELIMINARY REPORTCOLE AT; AVIS I; FRIED FA et al.1976; J. UROL.; U.S.A.; DA. 1976; VOL. 115; NO 3; PP. 234-238; BIBL. 16 REF.Article

ANTIGENIC CROSS REACTIVITY BETWEEN BENIGN PROSTATIC HYPERPLASIA AND ADENOCARCINOMA OF PROSTATE = REACTIVITE CROISEE ANTIGENIQUE ENTRE L'HYPERPLASIE PROSTATIQUE BENIGNE ET L'ADENOCARCINOME DE LA PROSTATEAVIS F; AVIS I; COLE AT et al.1975; UROLOGY; U.S.A.; DA. 1975; VOL. 5; NO 1; PP. 122-130; BIBL. 27 REF.Article

Scientific basis for cancer prevention : intermediate cancer markersMULSHINE, J. L; JETT, M; CUTTITTA, F et al.Cancer. 1993, Vol 72, Num 3, pp 978-983, issn 0008-543X, SUPConference Paper

Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitorsHONG, S. H; AVIS, I; VOS, M. D et al.Cancer research (Baltimore). 1999, Vol 59, Num 9, pp 2223-2228, issn 0008-5472Article

The correct dose : pharmacologically guided end point for anti-growth factor therapyMULSHINE, J. L; SHUKE, N; DAGHIGHIAN, F et al.Cancer research (Baltimore). 1992, Vol 52, Num 9, pp 2743s-2746s, issn 0008-5472Conference Paper

CERTAIN ASPECTS OF ANALYSIS OF COMPLEMENT DEPENDENT ANTIBODY IN BREAST CANCER PATIENTSHINDSLEY JP JR; AVIS I; NEWSOME JF et al.1979; J. SURG. ONCOL.; USA; DA. 1979; VOL. 11; NO 2; PP. 107-127; BIBL. 37 REF.Article

Expression of heterogeneous nuclear ribonucleoprotein A2/B1 in bronchial epithelium of chronic smokersZHOU, J; MULSHINE, J. L; RO, J. Y et al.Clinical cancer research. 1998, Vol 4, Num 7, pp 1631-1640, issn 1078-0432Article

Peptide amidating activity in human bronchoalveolar lavage fluidSCOTT, F. M; TRESTON, A. M; SHAW, G. L et al.Lung cancer. 1996, Vol 14, Num 2-3, pp 239-251, issn 0169-5002Article

Strategies for lung cancer chemopreventionMULSHINE, J. L; CUTTITTA, F; SCOTT, F et al.Lung cancer. 1993, Vol 9, Num 1-6, pp 357-360, issn 0169-5002Conference Paper

Growth factor effects on small cell lung cancer cells using a colorimetric assay: can a transferrin-like factor mediate autocrine growth?NAKANISHI, Y; CUTTITTA, F; KASPRZYK, P. G et al.Experimental cell biology. 1988, Vol 56, Num 1-2, pp 74-85, issn 0304-3568Article

Antitumor activity of a monoclonal antibody directed against gastrin-releasing peptide in patients with small cell lung cancerKELLEY, M. J; LINNOILA, R. I; AVIS, I. L et al.Chest. 1997, Vol 112, Num 1, pp 256-261, issn 0012-3692Article

Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancerCHAUDHRY, A; CARRASQUILLO, J. A; AVIS, I. L et al.Clinical cancer research. 1999, Vol 5, Num 11, pp 3385-3393, issn 1078-0432Article

Preclinical evaluation of an anti-autocrine growth factor monoclonal antibody for treatment of patients with small-cell lung cancerAVIS, I. L; KOVACS, T. O. G; KASPRZYK, P. G et al.Journal of the National Cancer Institute. 1991, Vol 83, Num 20, pp 1470-1476, issn 0027-8874Article